En Do Card It Is

Embed Size (px)

Citation preview

  • 7/31/2019 En Do Card It Is

    1/26

    Infective Endocarditis inChildren: an overview

    Thomas R. Burklow, MD

    LTC, MC

    Chief, Pediatric Cardiology,

    Walter Reed Army Medical Center

    All around nice guy

  • 7/31/2019 En Do Card It Is

    2/26

    Objectives

    Describe the incidence of IE in variouspediatric heart conditions.

    Review the Duke criteria of infective

    endocarditis Review the indications for prophylaxis and

    current recommendations for antimicrobial

    therapy. Review the efficacy and controversies in

    IE prophylaxis.

  • 7/31/2019 En Do Card It Is

    3/26

    Background

    Relatively rare in children

    Pre-antibiotic era: mortality was nearly100%

    Mortality approaches 15-25%

  • 7/31/2019 En Do Card It Is

    4/26

    Epidemiology

    Increasing incidence beginning in the 80s

    Increasing number of surgical patients Increasing number of complex congenital

    heart disease

    Increased use of prosthetic materials

    NICUs and PICUs

  • 7/31/2019 En Do Card It Is

    5/26

    Pathogenesis, Part 1

    Damaged endothelium

    undamaged endothelium not conducive tobacterial colonization

    endothelium can be damaged by high-velocityflows

    trauma to endothelium can induce

    thrombogenesis, leading to nonbacterialthrombotic endocarditis (NBTE). NBTE ismore receptive to colonization

  • 7/31/2019 En Do Card It Is

    6/26

  • 7/31/2019 En Do Card It Is

    7/26

    Pathogenesis, Part 2

    Microorganism No. %

    Streptococcus viridans 289 31.3

    Staphylococcus aureus 225 24.4

    Negative cultures 152 16.4

    Other streptoccal species (e.g. enterococci) 55 5.9

    HACEK and diphtheroids 50 5.4

    Gram negative bacilli 45 4.8

    Strept pneumoniae 18 1.9

    Fungi 14 1.5

    Others 28 3.0

    Berkowitz, FE: Infective endocarditis. IN Nichols EG, Cameron DE, Greeley WJ, et al (eds):Critical Heart Disease in Infants and Children. St. Louis, Mosby-Year Book, 1995.

  • 7/31/2019 En Do Card It Is

    8/26

    Microbiology

    S. Viridans Most common causative organism

    Gram negative bacilli

    Neonates and immunocompromised patients Prosthetic valves

    Within first year of surgery: Coag-negative staph

    After first year: similar to native valve endocarditis

    HACEK organisms Hemophilus, Actinobacillus, Cardiobacterium,

    Eikenella, Kingella

    Frequently affect damaged valves and can cause

    emboli

  • 7/31/2019 En Do Card It Is

    9/26

    Diagnosis

    Traditionally based upon positive blood

    cultures in the presence of a new orchanging heart murmur, or persistent

    fever in the presence of heart disease.

    Shortcomings include culture-negativeendocarditis, lack of typical

    echocardiographic findings, etc.

  • 7/31/2019 En Do Card It Is

    10/26

    Duke Criteria

    Based on pathological and clinical criteria.

    Utilizes microbiological data, evidence ofendocardial involvement, and other phenomenon

    associated with infective endocarditis to estimate theprobability of infective endocarditis in a givenpatient.

    Has been shown to be valid and reproducible in

    children

    Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilizationof specific echocardiographic findings. AM J Med 96:200, 1994

    Stockheim JA, Chadwick EG, Kessler S, et al. Are the Duke Criteria superior to the Beth Israel

    criteria for the diagnosis of infective endocarditis in children? Clin Infect Dis 27:1451, 1998

  • 7/31/2019 En Do Card It Is

    11/26

    Duke criteria

    Definitive Pathological criteria Microorganisms, or

    Pathologic lesions

    Clinical criteria

    2 major criteria, or

    1 major and 3 minor criteria, or

    5 minor

    Possible

    Findings consistent with infective endocarditis that fall short of definitive but are

    not rejected

    Rejected Firm alternative diagnosis, or

    Resolution of manifestations of endocarditis with antibiotic therapy of 4 days orless, or

    No pathological evidence of endocarditis at surgery or autopsy with antibiotictherapy of 4 days or less

  • 7/31/2019 En Do Card It Is

    12/26

    Duke criteria: Major criteria

    Positive blood culture

    Typical microorganism consistent with IE, from two separate bloodcultures

    S. viridans, S. bovis, HACEK

    community-acquired S. aureus or enterocci (no primary focus)

    Persistently positive cultures

    at least two positive cultures, drawn 12 hours apart

    all of three, or a majority of four or more cultures (with first and lastsample drawn at least one hour apart

    Evidence of endocardial involvement Positive echocardiogram

    oscillating intracardiac mass on valve or supporting structures, or

    myocardial abscess, or

    new partial dehiscence of prosthetic valve

    New valvar regurgitation

  • 7/31/2019 En Do Card It Is

    13/26

    The echocardiogram in IE

  • 7/31/2019 En Do Card It Is

    14/26

    Duke criteria: Minor criteria Predisposition

    Predisposing heart condition or IVdrug abuser

    Fever

    > 38.0 C

    Vascular phenomena

    arterial emboli, septic pulmonary

    infarct, mycotic aneurysm,intracranial hemorrhage,conjunctival hemorrhage,Janeways lesion

    Immunologic phenomena

    glomerulonephritis, Oslersnodes, Roths spots, rheumatoid

    factors Microbiologic evidence

    positive blood culture but doesnot meet major criteria as noted

    Echocardiographic evidence

    consistent with IE but does not

    meet major criteria as noted

  • 7/31/2019 En Do Card It Is

    15/26

    Sequelae

    Neurologic manifestations, 20%

    Cerebral emboli, mycotic aneurysms,cerebritis, brain abscess, hemorrhage, etc.

    Peripheral embolization

    Ischemia, infarction, mycotic aneurysms, etc

    Pulmonary infarction

    Renal insufficiency

    Congestive heart failure

  • 7/31/2019 En Do Card It Is

    16/26

    Prevention of IE

    No randomized controlled human trials whichdefinitively establishes the efficacy of antibioticprophylaxis.

    Most cases of endocarditis are NOT attributable toan invasive procedure

    Current recommendations are based upon literatureanalysis of procedure-related endocarditis,

    prophylaxis studies in experimental animal models,and retrospective analysis of human endocarditis

    Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis:Recommendations by the American Heart Association. JAMA 277;1794: 1997

  • 7/31/2019 En Do Card It Is

    17/26

    IE prophylaxis: Does it work? Strom BL. When data conflict with practice: rethinking the use of

    prophylactic antibiotics before dental treatment. LDI Issue Brief2001Mar;6(6):1-4

    Lockhart PB, Brennan MT, Fox PC, Norton HJ, Jernigan DB, StrausbaughLJ. Decision-making on the use of antimicrobial prophylaxis for dentalprocedures: a survey of infectious disease consultants and review. ClinInfect Dis. 2002 Jun 15;34(12):1621-6.

    Seymour RA, Lowry R, Whitworth JM, Martin MV. Infective endocarditis,dentistry and antibiotic prophylaxis; time for a rethink? Br Dent J2000 Dec9;189(11):610-6

    Strom BL, Abrutyn E, Berlin JA, Kinman JL, Feldman RS, Stolley PD,Levison ME, Korzeniowski OM, Kaye D. Dental and cardiac risk factors forinfective endocarditis. A population-based, case-control study. Ann Intern

    Med1998 Nov 15;129(10):761-9 Van der Meer JT, Van Wijk W, Thompson J, Vandenbroucke JP,

    Valkenburg HA, Michel MF. Efficacy of antibiotic prophylaxis for preventionof native-valve endocarditis. Lancet1992 Jan 18;339(8786):135-9

    Epstein JB. Infective endocarditis and dentistry: outcome-based research. JCan Dent Assoc1999 Feb;65(2):95-6

  • 7/31/2019 En Do Card It Is

    18/26

    Endocarditis prophylaxisrecommended

    High-risk Prosthestic cardiac valves

    Previous bacterial endocarditis

    Complex cyanotic heart disease

    Surgically constructed systemic-pulmonary shunts or conduits

    Moderate-risk Most other congenital heart disease

    Acquired valvar dysfunction

    Hypertrophic cardiomyopathy

    Mitral valve prolapse WITH regurgitation and/or thickenedleaflets

  • 7/31/2019 En Do Card It Is

    19/26

    Endocarditis prophylaxis NOTrecommended

    Isolated secundum ASD

    Surgically repaired VSD, ASD, or PDA after 6months (no residua)

    s/p CABG

    MVP without MR

    Previous Kawasaki disease w/o valvar

    dysfunction Previous rheumatic fever w/o valvar dysfunction

    Pacemakers and AICDs

    Flow murmurs

  • 7/31/2019 En Do Card It Is

    20/26

    Dental procedures and IEprophylaxis: Recommended

    Dental extractions

    Periodontal procedures

    Dental implants and reimplantation of avulsed teeth

    Endodontic proceures Subgingival placement of antibiotic fibers and strips

    Initial placement of orthodontic bands (not brackets)

    intraligamentary local anesthetic injections Prophylactic cleaning

  • 7/31/2019 En Do Card It Is

    21/26

    Dental procedures and IEprophylaxis: Not recommended

    Restorative dentistry

    Non-intraligamentary local anesthetic injections

    Taking oral impressions

    Fluoride treatments Oral radiographs

    Orthodontic appliance adjustment

    Shedding primary teeth

  • 7/31/2019 En Do Card It Is

    22/26

    Other procedures and IEprophylaxis: Recommended

    Respiratory

    T&A

    Surgical procedures involving respiratory mucosa

    Rigid bronchoscopy

    Gastrointestinal

    Sclerotherapy

    Esophageal stricture dilation

    ERCP with biliary obstruction Surgery involving biliary tract or intestinal mucosa

    Genitourinary tract

    Prostatic surgery, cystoscopy

    Urethral dilation

  • 7/31/2019 En Do Card It Is

    23/26

    Other procedures and IEprophylaxis: Not Recommended Respiratory

    Endotracheal intubation

    PE tubes

    Flexible bronchoscopy

    Gastrointestinal

    Transesophageal echocardiography

    Endoscopy (with or without biopsy)

    Circumcision Genitourinary tract

    Vaginal hysterectomy, and vaginal or Caesarean deliveries

    In uninfected tissues: urethral catheterization, uterine

    D&C, therapeutic abortions, sterilization procedures,insertion or removal of IUDs

  • 7/31/2019 En Do Card It Is

    24/26

    How aboutTattoos and Body piercing?

    Ear piercing 43% of respondents had ear piercing

    Only 6% took antibiotics

    23% reported infections but no IE reported

    Tattoos 5% of respondents had tattoos

    No antibiotics or infections reported

    Physicians Majority of physicians did not approve of piercing or tattoos

    60% felt that IE prophylaxis use was appropriate

    Cetta F, Graham LC, Lichtenberg RC, Warnes CA. Piercing and tattooing

    in patients with congenital heart disease. J Adolesc Health 1999;24:160

  • 7/31/2019 En Do Card It Is

    25/26

  • 7/31/2019 En Do Card It Is

    26/26

    References Bayer AS, Bolger AF, Taubert KA, Wilson W, Steckelberg J, Karchmer AW, et al. Diagnosis and Management of

    Infective Endocarditis and Its Complications. Circulation. 1998;98:2936-2948. Berkowitz, FE: Infective endocarditis. IN Nichols EG, Cameron DE, Greeley WJ, et al (eds):Critical Heart Disease in Infants and Children. St. Louis, Mosby-Year Book, 1995.

    Cetta F, Graham LC, Lichtenberg RC, Warnes CA. Piercing and tattooing in patients with congenital heartdisease. J Adolesc Health 1999;24:160

    Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: Recommendations by the AmericanHeart Association. JAMA 277;1794: 1997

    Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specificechocardiographic findings. AM J Med 96:200, 1994

    Epstein JB. Infective endocarditis and dentistry: outcome-based research. J Can Dent Assoc1999 Feb;65(2):95-6 Lockhart PB, Brennan MT, Fox PC, Norton HJ, Jernigan DB, Strausbaugh LJ. Decision-making on the use of

    antimicrobial prophylaxis for dental procedures: a survey of infectious disease consultants and review. Clin InfectDis. 2002 Jun 15;34(12):1621-6.

    Seymour RA, Lowry R, Whitworth JM, Martin MV. Infective endocarditis, dentistry and antibiotic prophylaxis; timefor a rethink? Br Dent J2000 Dec 9;189(11):610-6

    Stockheim JA, Chadwick EG, Kessler S, et al. Are the Duke Criteria superior to the Beth Israel criteria for thediagnosis of infective endocarditis in children? Clin Infect Dis 27:1451, 1998

    Strom BL, Abrutyn E, Berlin JA, Kinman JL, Feldman RS, Stolley PD, Levison ME, Korzeniowski OM, Kaye D.

    Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study. Ann Intern Med1998 Nov 15;129(10):761-9

    Strom BL. When data conflict with practice: rethinking the use of prophylactic antibiotics before dental treatment.LDI Issue Brief2001 Mar;6(6):1-4

    Taubert KA and Dajani AS. Infective Endocarditis IN Garson A, Bricker JT, Fisher DJ, and Neish SR, eds. TheScience and Practice of Pediatric Cardiology. Williams and Wilkins. Baltimore. 1998. Pp. 768-779.

    Van der Meer JT, Van Wijk W, Thompson J, Vandenbroucke JP, Valkenburg HA, Michel MF. Efficacy of antibioticprophylaxis for prevention of native-valve endocarditis. Lancet1992 Jan 18;339(8786):135-9